Elekta invites stakeholders to Capital Markets Day
The event occurs on June 17, 2026, at 14:00 CEST with CEO and CFO presentations on strategy and financial targets. Register by June 12.
See the latest news and media coverage for Elekta. We track all announcements, press releases, and industry mentions in real time, all in one place.
Precision radiotherapy solutions provider
elekta.comLast updated
In short: Elekta transitioned leadership with CEO Jakob Just-Bomholt, launched a major cost-reduction plan, and secured FDA clearance for the Evo CT-Linac.
The event occurs on June 17, 2026, at 14:00 CEST with CEO and CFO presentations on strategy and financial targets. Register by June 12.
It gains CE clearance for intractable epilepsy, offering up to 85% seizure control improvement in studies.
Sales rose 2% in constant exchange rates to SEK 4,239 M. Book-to-bill ratio hit 1.17. Restructuring charge of SEK 417 M impacted results. Adjusted gross margin improved to 38.3%.
Elekta announces employee reduction of 450 for SEK 500M annual savings, outlines four must-win battles: Simplify, Empower, Speed; Focused Innovation; Win in the U.S.; Expand in China.
The development is similar on leading European stock exchanges. On the news front, some companies have released their quarterly reports. At 12.50, the OMXS30 index is up 0.37 percent to 3,129.46...
Third quarterIn constant exchange rates, net sales increased by 2 percent mainly driven by Europe and China. Reported sales in SEK decreased by 10 percent...
The radiation therapy company Elekta is traded up after its interim report on Thursday, a report that SB 1 sees as positive for the results development. "We expect...
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. To further protect the integrity of our editorial content, we keep...
Track Elekta and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.